INSECTICIDES (INDIA) LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 581 INR | -0.16% |
|
+5.06% | -14.15% |
| Mar. 26 | Insecticides Limited Announces Reconstitution of Committees | CI |
| Feb. 06 | Transcript : Insecticides Limited, Q3 2024 Earnings Call, Feb 06, 2024 |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -14.15% | 207M | - | ||
| +2.08% | 3.63B | C- | ||
| -19.91% | 2.16B | C+ | ||
| -7.20% | 1.98B | B- | ||
| +2.34% | 1.87B | - | ||
| +1.54% | 1.73B | - | ||
| -3.83% | 1.28B | B | ||
| +3.39% | 1.18B | - | ||
| -18.55% | 1.08B | - | ||
| +2.18% | 1.06B | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
- Stock Market
- Equities
- INSECTICID Stock
- Ratings Insecticides (India) Limited